Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Nalmefene by Orexo for Acute Opioid Overdosage: Likelihood of Approval
Nalmefene is under clinical development by Orexo and currently in Phase I for Acute Opioid Overdosage. According to GlobalData, Phase...